Jingyuan Wen

5.3k total citations · 2 hit papers
124 papers, 4.0k citations indexed

About

Jingyuan Wen is a scholar working on Molecular Biology, Pharmaceutical Science and Cancer Research. According to data from OpenAlex, Jingyuan Wen has authored 124 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 39 papers in Pharmaceutical Science and 16 papers in Cancer Research. Recurrent topics in Jingyuan Wen's work include Advanced Drug Delivery Systems (23 papers), Advancements in Transdermal Drug Delivery (22 papers) and RNA Interference and Gene Delivery (9 papers). Jingyuan Wen is often cited by papers focused on Advanced Drug Delivery Systems (23 papers), Advancements in Transdermal Drug Delivery (22 papers) and RNA Interference and Gene Delivery (9 papers). Jingyuan Wen collaborates with scholars based in New Zealand, China and Australia. Jingyuan Wen's co-authors include Manisha Sharma, James R. Falconer, Michelle Locke, Siew Young Quek, Junnan Liang, Sara M. Hanning, Sanjukta Duarah, Shuo Chen, Liang Chu and Indrawati Oey and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and ACS Nano.

In The Last Decade

Jingyuan Wen

116 papers receiving 3.9k citations

Hit Papers

Recent advances in non-ionic surfactant vesicles (niosome... 2019 2026 2021 2023 2019 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingyuan Wen New Zealand 37 1.4k 1.0k 686 495 486 124 4.0k
Abbas Pardakhty Iran 38 1.6k 1.1× 1.1k 1.1× 424 0.6× 678 1.4× 260 0.5× 143 4.5k
Nabil A. Alhakamy Saudi Arabia 34 1.5k 1.1× 1.1k 1.1× 378 0.6× 861 1.7× 211 0.4× 214 4.5k
Hélder Ferreira Teixeira Brazil 34 1.2k 0.8× 877 0.9× 894 1.3× 367 0.7× 154 0.3× 170 3.7k
Luisa Di Marzio Italy 40 1.6k 1.1× 918 0.9× 420 0.6× 597 1.2× 150 0.3× 103 3.8k
Yunjin Jung South Korea 37 2.4k 1.7× 697 0.7× 247 0.4× 618 1.2× 1.2k 2.4× 144 5.6k
Chi‐Feng Hung Taiwan 41 1.3k 0.9× 422 0.4× 450 0.7× 361 0.7× 135 0.3× 132 4.4k
Chiara Dianzani Italy 42 2.0k 1.4× 542 0.5× 172 0.3× 781 1.6× 344 0.7× 124 4.8k
Imran Kazmi Saudi Arabia 42 2.5k 1.7× 350 0.3× 286 0.4× 546 1.1× 1.2k 2.5× 296 6.3k
In‐Soo Yoon South Korea 36 1.7k 1.2× 733 0.7× 303 0.4× 1.1k 2.3× 128 0.3× 182 4.7k
Ashish Kumar Agrawal India 35 2.4k 1.7× 1.0k 1.0× 213 0.3× 859 1.7× 1.0k 2.1× 140 4.5k

Countries citing papers authored by Jingyuan Wen

Since Specialization
Citations

This map shows the geographic impact of Jingyuan Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyuan Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyuan Wen more than expected).

Fields of papers citing papers by Jingyuan Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyuan Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyuan Wen. The network helps show where Jingyuan Wen may publish in the future.

Co-authorship network of co-authors of Jingyuan Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Jingyuan Wen. A scholar is included among the top collaborators of Jingyuan Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyuan Wen. Jingyuan Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jia, Fang, Xiaoxing Fan, Licheng Wu, et al.. (2025). Enhanced lymphatic transportation of SLN by mimicking oligopeptide transportation route. Asian Journal of Pharmaceutical Sciences. 20(3). 101019–101019. 2 indexed citations
2.
Yu, Qin, Zhenyu Chang, Baozhong Sun, et al.. (2025). A delayed-melting cryomicroneedle system for probiotic delivery against invasive Candida albicans infection. Journal of Controlled Release. 385. 114016–114016. 2 indexed citations
3.
Harris, Paul W. R., et al.. (2025). Enhancing the Oral Bioavailability of Glutathione Using Innovative Analogue Approaches. Pharmaceutics. 17(3). 385–385. 2 indexed citations
4.
Cornish, Jillian, Jianming Lin, Janesha Perera, et al.. (2025). LACTOFERRIN ENHANCES THE ANTIBIOTIC TREATMENT OF STAPHYLOCOCCUS AUREUS IN BONE INFECTION. Biochemistry and Cell Biology. 103. 1–5.
5.
Xiao, Xin, et al.. (2024). Enhanced oral and pulmonary delivery of biomacromolecules via amplified transporter targeting. Journal of Controlled Release. 370. 152–167. 7 indexed citations
6.
Spicer, Julie A., et al.. (2024). Advancements in oral insulin: A century of research and the emergence of targeted nanoparticle strategies. European Journal of Lipid Science and Technology. 126(7). 8 indexed citations
7.
Zhu, Yongchao, et al.. (2024). Co‐encapsulation of ω‐3 LC‐PUFAs and carotenoids for enhanced synergistic antioxidant effects. SHILAP Revista de lepidopterología. 5(5). 4 indexed citations
8.
Li, Haorong, Wenli Zhang, Yan Shen, et al.. (2024). Hair Follicle-Targeted Delivery of Azelaic Acid Micro/Nanocrystals Promote the Treatment of Acne Vulgaris. International Journal of Nanomedicine. Volume 19. 5173–5191. 10 indexed citations
10.
Li, Binghua, et al.. (2024). Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma. Clinical and Molecular Hepatology. 31(1). e31–e34. 1 indexed citations
11.
Wei, Yi, Tuying Yong, Wenlong Jia, et al.. (2023). Bone Lesion‐Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5‐Targeting miR‐3190‐5p. Advanced Science. 10(17). e2207080–e2207080. 19 indexed citations
12.
Wei, Yi, Jingyuan Wen, Jingyu Liao, et al.. (2023). E26 transformation-specific transcription variant 5 in development and cancer: modification, regulation and function. Journal of Biomedical Science. 30(1). 17–17. 10 indexed citations
13.
Wu, Yao, Yongping Li, Guo‐Liang Lu, et al.. (2023). Nitric Oxide-Loaded Bioinspired Lipoprotein Normalizes Tumor Vessels To Improve Intratumor Delivery and Chemotherapy of Albumin-Bound Paclitaxel Nanoparticles. Nano Letters. 23(3). 939–947. 26 indexed citations
14.
Chen, Shuo, et al.. (2022). Chitosan-based microneedle arrays for dermal delivery of Centella asiatica. International Journal of Pharmaceutics. 627. 122221–122221. 44 indexed citations
15.
Chen, Shuo, et al.. (2021). Anti-ageing peptides and proteins for topical applications: a review. Pharmaceutical Development and Technology. 27(1). 108–125. 22 indexed citations
16.
Sharma, Manisha, et al.. (2020). Preformulation studies of l-glutathione: physicochemical properties, degradation kinetics, and in vitro cytotoxicity investigations. Drug Development and Industrial Pharmacy. 46(5). 717–731. 10 indexed citations
17.
Huang, Zhao, Jingyuan Wen, Jingjing Yu, et al.. (2020). MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner. Journal of Experimental & Clinical Cancer Research. 39(1). 150–150. 28 indexed citations
18.
Yu, Xi-Yong, Lin Shu-guang, Zhi-Wei Zhou, et al.. (2007). Role of P-Glycoprotein in the Intestinal Absorption of Tanshinone IIA, a Major Active Ingredient in the Root of Salvia miltiorrhiza Bunge. Current Drug Metabolism. 8(4). 325–340. 61 indexed citations
20.
Wen, Jingyuan, Robin Ledger, B. J. McLeod, et al.. (2002). Protein and peptide degradation in the intestine of the common brushtail possum ( Trichosurus vulpecula ). Journal of Comparative Physiology B. 172(7). 553–559. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026